Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.
This study has been completed.
Study NCT00317161.   Last updated on October 9, 2008.
Information provided by GlaxoSmithKline
Please refer to this study by its ClinicalTrials.gov identifier: NCT00317161
Locations
Thailand
GSK Investigational Site
Songkla, Thailand, 90110
GSK Investigational Site
Khon Kaen, Thailand, 40002
GSK Investigational Site
Bangkok, Thailand, 10400
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline